IBC
Fireside Chat: The Future of Clinical Trials and Site Engagement
The COVID-19 pandemic has proven that research can be done more efficiently. To make these efficiencies sustainable, the sites’ perspective must be considered. Sponsors, CROs, and sites should engage early ...
Introducing Fireside Chats: Conversations On Burning Research Topics
Advarra is excited to introduce Fireside Chats, a series of virtual conversations. Fireside Chat is an informal conversation between an Advarra representative, and a clinical research thought leader.
Q&A Part 1 – Gene Therapy Research in the Age of COVID-19
Panelists from Advarra’s inaugural virtual symposium participated in a Q&A session to address questions submitted by the audience. Read part 1:
Q&A Part 2 – Gene Therapy Research in the Age of COVID-19
Expert panelists from Advarra’s gene therapy virtual symposium address some of the most popular questions submitted by the audience. Read part 2:
Virtual Symposium: Gene Therapy Research in the Age of COVID-19
Gene therapy research is expanding rapidly in the clinical setting, especially in oncology, rare diseases, and infectious diseases—in fact, gene therapy research plays a crucial role in responding to the ...
Safety Precautions for Laboratory Research With COVID-19 Specimens
The pandemic has brought biosafety to the spotlight. This blog discusses guidelines and safety precautions for handling COVID-19 specimens.
Clinical Trials Day: Thanking the Unsung Heroes
On Clinical Trials Day, now more than ever, it’s important to recognize and thank those unsung heroes at the focal point of research: research sites and institutions. Read more:
Virtual Symposium: Gene Therapy Research in the Age of COVID-19
The coronavirus pandemic has brought genetic research to the forefront. To address emerging issues, Advarra presents its first virtual symposium. Read more:
Safety Precautions for Laboratory Research with SARS-CoV-2 Positive Specimens and COVID-19 Subjects
Daniel Eisenman authored the article "Safety Precautions for Laboratory Research with SARS-CoV-2 Positive Specimens and COVID-19 Subjects" in Clinical Researcher.
Empowering Employees Starts with Building a Strong Culture
Everyone wants to be part of a strong work culture, but how does your organization get there? Check out three tips for building a stronger work culture.
How Sites Can Prepare for COVID-19 Genetically Engineered Vaccine Studies
Is your site prepared to participate in COVID-19 vaccine research? Registering an IBC ahead of time gives you an advantage. Read more:
How Research Informs the COVID-19 Response
Research doesn’t just inform medical treatment; it informs public health and public policy, and it helps explain human behaviors. Read more: